Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity ...

The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost ...

We're trying to set the stage for integrating these ideas" Anthony Vella, professor and Boehringer Ingelheim Chair in ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an FDA-approved treatment.

Some bat species can live cancer-free for up to 25 years, which is equivalent to 180 human years. How do they do it?

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

Canine mast cell tumours (MCTs) represent one of the most prevalent neoplasms in dogs, characterised by their markedly heterogeneous clinical behaviour. These tumours, ranging from benign lesions ...

A new study by scientists at the University of North Carolina at Chapel Hill reveals that the cells shaping our organs may be ...

City of Hope researchers have co-led the first study to demonstrate that characterizing genetic material near chromosomes ...

Since the time of the ancient Greek physician Hippocrates, cancer has been recognized as being sensitive to heat. Today, this ...